Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.71 |
| ▸ | CA1 | P00915 | 1/20 | 0.71 |
| ▸ | CA2 | P00918 | 1/20 | 0.71 |
| ▸ | CA4 | P22748 | 1/20 | 0.71 |
| ▸ | IAPP | P10997 | 4/20 | 0.70 |
| ▸ | BACE1 | P56817 | 1/20 | 0.57 |
| ▸ | ERN1 | O75460 | 1/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
| ▸ | JUN | P05412 | 1/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.52 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.50 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.50 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.50 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31083592 | 1.00 | NFKB1 (0.71) | NFKB1CA1CA2CA4IAPP | |
| SCHEMBL31256670 | 1.00 | NFKB1 (0.71) | NFKB1CA1CA2CA4IAPP | |
| SCHEMBL89185 | 1.00 | NFKB1 (0.71) | NFKB1CA1CA2CA4IAPP | |
| SCHEMBL12189733 | 0.85 | IAPP (0.66) | NFKB1CA1CA2CA4IAPP | |
| SCHEMBL9094389 | 0.84 | NFKB1 (0.66) | NFKB1CA1CA2CA4IAPP | |
| O-Coumaric Acid SCHEMBL29368085 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL892006 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL29367602 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL64885 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL29353381 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS INC. | 2024-09-03 | — | — | US | claimed |
| EP-4101870-A1 | POLYMER COMPOUND, METHOD FOR PRODUCING POLYMER COMPOUND, ADHESIVE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING ADHESIVE COMPOSITION, AND METHOD FOR ADJUSTING ADHESIVE STRENGTH | National Institute for Materials Science (JP) | 2022-12-14 | — | — | EP | claimed |
| US-20220096463-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2022-03-31 | — | — | US | claimed |
| US-11234975-B2 | Levorphanol prodrugs and processes for making and using them | KEMPHARM, INC. (US) | 2022-02-01 | — | — | US | claimed |
| US-20210002226-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2021-01-07 | — | — | US | claimed |
| US-20200390757-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2020-12-17 | — | — | US | claimed |
| WO-2018191474-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | KEMPHARM, INC. (US) | 2018-10-18 | — | — | WO | claimed |
| WO-2018191472-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | KEMPHARM, INC. (US) | 2018-10-18 | — | — | WO | claimed |
| US-20170312270-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | ALTER DOMUS (US) LLC | 2017-11-02 | — | — | US | claimed |
| EP-3226907-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS AND MAKING AND USE THEREOF | Kempharm, Inc. (US) | 2017-10-11 | — | — | EP | claimed |
| EP-2448408-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF | Kempharm, Inc. (US) | 2012-05-09 | — | — | EP | claimed |
| EP-2205557-B1 | METHOD FOR PRODUCING BETA-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2012-02-29 | — | — | EP | claimed |
| WO-2011002995-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2011-01-06 | — | — | WO | claimed |
| US-20110002991-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF | ALTER DOMUS (US) LLC | 2011-01-06 | — | — | US | claimed |
| US-20110004017-A1 | METHOD FOR PRODUCING B-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-06 | — | — | US | claimed |
| WO-2009042402-A2 | COMPOSITION AND METHOD FOR TREATING ROSACEA | LIPO CHEMICALS INC. (US) | 2009-04-02 | — | — | WO | claimed |
| US-20080214669-A1 | Composition and Method For Treating Hyperpigmented Skin | LIPO CHEMICALS INC. (US) | 2008-09-04 | — | — | US | claimed |
| WO-2008073684-A1 | COMPOSITION FOR TREATING AGING SKIN COMPRISING A HYDROXYCINNAMIC ACID SUCH AS P-COUMARIC ACID | LIPO CHEMICALS INC. (US) | 2008-06-19 | — | — | WO | claimed |
| CN-101141943-A | Composition and method for treating hyperpigmented skin | LIPO CHEMICALS INC (US) | 2008-03-12 | — | — | CN | claimed |
| US-20070166251-A1 | Composition and method for treating hyperpigmented skin | LIPO CHEMICALS INC. (US) | 2007-07-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390757-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OPRM1, OPRL1, OPRK1 | NFKB1 4528/4885CA1 1503/4885CA2 3018/4885 |
| US-20170312270-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | OPRM1, OPRK1, OPRD1 | NFKB1 437/4885CA1 1451/4885CA2 1603/4885 |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | NFKB1 4528/4885CA1 1503/4885CA2 3018/4885 |
| US-20080214669-A1 | Composition and Method For Treating Hyperpigmented Skin | MC1R, MMS19, CUTA | NFKB1 405/4885CA1 4657/4885CA2 4497/4885 |
| US-20110002991-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF | CYP7A1, CYP2B6, CYP2D6 | NFKB1 2203/4885CA1 1750/4885CA2 3052/4885 |
| US-20070166251-A1 | Composition and method for treating hyperpigmented skin | MMS19, CUTA, FAM20C | NFKB1 440/4885CA1 4322/4885CA2 4380/4885 |
| US-11234975-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | NFKB1 4528/4885CA1 1503/4885CA2 3018/4885 |
| US-20210002226-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OPRM1, OPRK1, OPRD1 | NFKB1 4553/4885CA1 1583/4885CA2 2763/4885 |
| US-20220096463-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OPRM1, OPRL1, OPRK1 | NFKB1 4528/4885CA1 1503/4885CA2 3018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.